Proteinopathies as Hallmarks of Impaired Gene Expression, Proteostasis and Mitochondrial Function in Amyotrophic Lateral Sclerosis.

Benson, Bridget C; Shaw, Pamela J; Azzouz, Mimoun; Highley, J Robin; Hautbergue, Guillaume M

Benson, Bridget C; Shaw, Pamela J; Azzouz, Mimoun; Highley, J Robin; Hautbergue, Guillaume M.

Afiliación

Benson BC; Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, United Kingdom.
Shaw PJ; Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, United Kingdom.
Azzouz M; Neuroscience Institute, University of Sheffield, Sheffield, United Kingdom.
Highley JR; Department of Neuroscience, Sheffield Institute for Translational Neuroscience (SITraN), University of Sheffield, Sheffield, United Kingdom.
Hautbergue GM; Neuroscience Institute, University of Sheffield, Sheffield, United Kingdom.

Front Neurosci ; 15: 783624, 2021.

Article en En | MEDLINE | ID: mdl-35002606

Palabras clave

RNA metabolism alteration; amyotrophic lateral sclerosis; impaired proteostasis; mitochondrial dysfunction; proteinopathies

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Neurosci Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Neurosci Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido